Demographics (1)
- sex - Gender of participant (phv00252145.v1.p1)
Other (16)
- AFFECTION_STATUS - Case or control status of the subjects (phv00252140.v1.p1)
- ANALYTE TYPE - Analyte type (phv00252148.v1.p1)
- BODY SITE - Body site of sample origin (phv00252147.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00252139.v1.p1)
- HISTOLOGICAL TYPE - Cell or tissue type or subtype of sample (phv00252150.v1.p1)
- IS_TUMOR - Tumor status (phv00252149.v1.p1)
- PRIMARY TUMOR LOCATION - Primary tumor location (phv00252152.v1.p1)
- PRIMARY_METASTATIC_TUMOR - Primary tumor, metastasis, or transformed cell line (phv00252151.v1.p1)
- SAMPLE_ID - De-identified sample ID (phv00252146.v1.p1)
- SAMPLE_ID - Sample ID (phv00252142.v1.p1)
- SAMPLE_USE - Sample use. Seq_DNA_SNP_MAF_Ind: Sample(s) were used to generate aggregate mutation annotation file (.maf) with individual SNP genotypes; Seq_DNA_WholeExome: Whole exome sequencing (phv00252143.v1.p1)
- SEQUENCING_CENTER - Name of the center which conducted sequencing (phv00252154.v1.p1)
- SUBJECT_ID - Subject ID (phv00252138.v1.p1)
- SUBJECT_ID - Subject ID (phv00252141.v1.p1)
- SUBJECT_ID - De-identified subject ID (phv00252144.v1.p1)
- TUMOR_STAGE - Tumor stage of sample (phv00252153.v1.p1)